Innovation Pharmaceuticals Inc. (IPIX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 18 Thousand | - | 423 Thousand | - | - |
| Cost of Revenue | 373 Thousand | 382 Thousand | 378 Thousand | - | 371 Thousand | 413 Thousand |
| Gross Profit | -373 Thousand | -364 Thousand | -378 Thousand | 423 Thousand | -371 Thousand | -413 Thousand |
| Operating Expenses | 3.11 Million | 6.77 Million | 9.01 Million | 5.05 Million | 6.45 Million | 13.94 Million |
| Selling, General and Administrative Expenses | 1.47 Million | 1.96 Million | 1.99 Million | 2.26 Million | 2.1 Million | 2.57 Million |
| Research and Development Expenses | 1.46 Million | 4.81 Million | 7.01 Million | 2.79 Million | 4.34 Million | 11.36 Million |
| Other Expenses | 172 Thousand | -5000.00 | 499 Thousand | 102 Thousand | 357 Thousand | 517 Billion |
| Cost and Expenses | 3.11 Million | 6.77 Million | 9.01 Million | 5.05 Million | 6.45 Million | 13.94 Million |
| Operating Income | -3.11 Million | -6.92 Million | -9.01 Million | -4.63 Million | -6.45 Million | -13.94 Million |
| Interest Expense | 57 Thousand | 115 Thousand | 4.85 Million | 260 Thousand | 2.19 Million | 202 Thousand |
| Income Tax Expense | - | 120 Thousand | 4.85 Million | 362 Thousand | 390 Thousand | -2.21 Million |
| Earnings before Tax | -3.16 Million | -7.04 Million | -13.87 Million | -6.64 Million | -8.68 Million | -16.36 Million |
| Net Income | -3.16 Million | -7.16 Million | -18.72 Million | -7.01 Million | -9.07 Million | -16.36 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.05 | -0.03 | -0.05 | -0.11 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.05 | -0.03 | -0.05 | -0.11 |
| Weighted Average Shares Outstanding | 505.76 Million | 503.86 Million | 386.16 Million | 237.29 Million | 178.22 Million | 144.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 505.76 Million | 503.86 Million | 386.16 Million | 237.29 Million | 178.22 Million | 144.51 Million |
| Gross Margin | - | -20.22 | - | 1.00 | - | - |
| EBIT Margin | - | -355.72 | - | -9.83 | - | - |
| Profit Margin | - | -397.83 | - | -16.57 | - | - |
| EBITDA | -2.73 Million | -6.54 Million | -8.63 Million | -6.01 Million | -6.11 Million | -13.52 Million |
| Earnings Before Tax Margin | - | -384.50 | - | -10.96 | - | - |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 6000.00 | - | -6000.00 | - | - | - |
| Cost of Revenue | 94 Thousand | 373 Thousand | 93 Thousand | 94 Thousand | 94 Thousand | - |
| Gross Profit | -88 Thousand | -373 Thousand | -99 Thousand | -94 Thousand | -94 Thousand | - |
| Operating Expenses | 229 Thousand | 2.56 Million | 583 Thousand | 641 Thousand | 333 Thousand | 1.38 Million |
| Selling, General and Administrative Expenses | 521 Thousand | - | 280 Thousand | 318 Thousand | 366 Thousand | 513 Thousand |
| Research and Development Expenses | 208 Thousand | - | 303 Thousand | 323 Thousand | -33 Thousand | 869 Thousand |
| Other Expenses | 21 Thousand | 482 Thousand | 78 Thousand | 126 Thousand | 52 Thousand | - |
| Cost and Expenses | 229 Thousand | 2.93 Million | 583 Thousand | 641 Thousand | 333 Thousand | 1.38 Million |
| Operating Income | -223 Thousand | -2.93 Million | -672 Thousand | -679 Thousand | -347 Thousand | -1.41 Million |
| Interest Expense | 14 Thousand | 57 Thousand | 9000.00 | 19 Thousand | 14 Thousand | 15 Thousand |
| Income Tax Expense | -94 Thousand | - | -80 Thousand | 31 Thousand | 14 Thousand | -16 Thousand |
| Earnings before Tax | -179 Thousand | -3.16 Million | -681 Thousand | -698 Thousand | -361 Thousand | -1.42 Million |
| Net Income | -179 Thousand | -3.16 Million | -681 Thousand | -729 Thousand | -375 Thousand | -1.42 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 518.34 Million | 505.76 Million | 518.34 Million | 496.93 Million | 503.84 Million | 503.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 518.34 Million | 505.76 Million | 518.34 Million | 496.93 Million | 503.84 Million | 503.96 Million |
| Gross Margin | -14.67 | - | 16.50 | - | - | - |
| EBIT Margin | -37.17 | - | 96.50 | - | - | - |
| Profit Margin | -29.83 | - | 113.50 | - | - | - |
| EBITDA | -223 Thousand | - | -579 Thousand | -586 Thousand | -253 Thousand | -1.32 Million |
| Earnings Before Tax Margin | -37.17 | - | 112.00 | - | - | - |
G
ADJ
CTCGF
5945
VRDR
AMEN